Advanced Colorectal Cancer

Adenocarcinoma of the Caecum

Male, 46 years

Patient Internal ID: 1623344272

ICD-10 code

C18.0 Malignant Neoplasm of Caecum

Diagnosis (Incl. Metastases/Stage) and Year

February 2014
Adenocarcinoma of Caecum (G2), (KRAS mutated) with Omental Metastasis.
Disease progression in May 2020: Metastasis in Liver.

Previous Treatment

Chemotherapy (Avastin + FOLFOX), Surgery (Right Hemicolectomy, Omentectomy and Peritonectomy), HIPEC (Oxaliplatin), Chemotherapy (Avastin + FOLFOX), Chemotherapy (Avastin + FOLFIRI), Surgery (Hemi Hepatectomy), Chemotherapy (5-FU Grammont’s scheme), Percutaneous Transhepatic MW ablation of Liver.

Prognosis and Survival Expectation

The prognosis remains poor, with a median survival of Advanced Colorectal Cancer ~24 months from diagnosis.
5-year relative survival rates for Advanced Colon Cancer are 13%.

Treatment Provided

Allogeneic Umbilical Cord Blood Derived NK Cells (4 doses) and Curcumin Infusions over a period of 1 month. Autologous DCV (4 doses) and CIK (4 doses) over a period of 2 months.

Patient Survival/Condition and Year
Date of Review: 20/01/2024

The patient has survived for over 8 years since the diagnosis and 3 years after the recurrence and progression of the disease. It can be concluded that the addition of Immunotherapy, alongside Surgery and Chemotherapy, has extended patient survival by an estimate of 13 months.